Related Experiment Video
Updated: Jul 15, 2026
05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and
Michael Linden1, Franz X Eich, Lena Pyrkosch
1Research Group Psychosomatic Rehabilitation, Charité, University Hospital Benjamin Franklin, Germany. michael.linden@charite.de
International Clinical Psychopharmacology
|April 7, 2007
Summary
Physicians differentiate between atypical antipsychotics, not viewing them as a single class. Treatment choices for schizophrenia reflect specific drug profiles, such as weight gain and extrapyramidal symptoms, when switching medications.
Area of Science:
- Pharmacology
- Psychiatry
- Drug Utilization
Background:
- Atypical antipsychotics are frequently grouped as a single drug class.
- Significant pharmacological differences exist among atypical antipsychotics.
- Practitioner differentiation between these compounds is not well understood.
Purpose of the Study:
- To investigate whether physicians differentiate between atypical antipsychotics.
- To understand the extent to which specific drug profiles influence treatment decisions.
Main Methods:
- A drug utilization study involving 472 outpatients with schizophrenia.
- Patients were switched from olanzapine or risperidone to amisulpride.
- Data collected included patient demographics, illness characteristics, treatment details, and reasons for switching.
Main Results:
- Reasons for switching from olanzapine to amisulpride included weight gain (72.6%) and expected lower weight gain (84.1%).
- Reasons for switching from risperidone to amisulpride included extrapyramidal symptoms (58.5%) and expected fewer extrapyramidal symptoms (82.5%).
- Patient requests were also a significant factor in switching (60.2% from olanzapine).
Conclusions:
- Physicians do not perceive atypical antipsychotics as a homogeneous class.
- Treatment decisions are influenced by the distinct pharmacological profiles of individual atypical antipsychotic drugs.
- This differentiation supports the clinical relevance of specific drug characteristics in managing schizophrenia.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...